Trials / Recruiting
RecruitingNCT07455864
Lysosomal Acid Lipase Deficiency in Risk Groups
A Multicenter Real-world Observational Study of the Prevalence, Diagnostic Pathways, and Clinical Characteristics of Lysosomal Acid Lipase Deficiency in Pediatric and Adolescent Risk Groups in the Russian Federation (HELIOS)
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,200 (estimated)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
A multicenter real-world observational study of the prevalence, diagnostic pathways, and clinical characteristics of lysosomal acid lipase deficiency in pediatric and adolescent risk groups in the Russian Federation (HELIOS)
Conditions
Timeline
- Start date
- 2026-02-25
- Primary completion
- 2028-06-30
- Completion
- 2028-06-30
- First posted
- 2026-03-06
- Last updated
- 2026-04-14
Locations
2 sites across 1 country: Russia
Source: ClinicalTrials.gov record NCT07455864. Inclusion in this directory is not an endorsement.